These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15308988)

  • 1. Turning necrosis into apoptosis: the exacting task that can enhance survival.
    Chen-Scarabelli C; Scarabelli TM
    Am Heart J; 2004 Aug; 148(2):196-9. PubMed ID: 15308988
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical implications of apoptosis in ischemic myocardium.
    Scarabelli TM; Knight R; Stephanou A; Townsend P; Chen-Scarabelli C; Lawrence K; Gottlieb R; Latchman D; Narula J
    Curr Probl Cardiol; 2006 Mar; 31(3):181-264. PubMed ID: 16503249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and left ventricular remodelling after myocardial infarction.
    Hori M; Nishida K
    Cardiovasc Res; 2009 Feb; 81(3):457-64. PubMed ID: 19047340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo protective effects of urocortin on ischemia-reperfusion injury in rat heart via free radical mechanisms.
    Liu CN; Yang C; Liu XY; Li S
    Can J Physiol Pharmacol; 2005 Jun; 83(6):459-65. PubMed ID: 16049545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family.
    Davidson SM; Rybka AE; Townsend PA
    Biochem Pharmacol; 2009 Jan; 77(2):141-50. PubMed ID: 18817752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Charalampopoulos I; Spiess J; Gravanis A; Margioris AN
    FEBS Lett; 2005 Aug; 579(20):4259-64. PubMed ID: 16054139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential uses of corticotropin-releasing hormone antagonists.
    Zoumakis E; Rice KC; Gold PW; Chrousos GP
    Ann N Y Acad Sci; 2006 Nov; 1083():239-51. PubMed ID: 17148743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
    Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Fas-mediated apoptosis in neutrophils after surgery-induced acute inflammation.
    Iwase M; Kondo G; Watanabe H; Takaoka S; Uchida M; Ohashi M; Nagumo M
    J Surg Res; 2006 Jul; 134(1):114-23. PubMed ID: 16376940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective action of urocortin in early pre- and postconditioning.
    Cserepes B; Jancsó G; Gasz B; Rácz B; Ferenc A; Benkó L; Borsiczky B; Kürthy M; Ferencz S; Lantos J; Gál J; Arató E; Miseta A; Wéber G; Róth E
    Ann N Y Acad Sci; 2007 Jan; 1095():228-39. PubMed ID: 17404036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urocortin: a cardiac protective peptide?
    Tao J; Li S
    Biochem Biophys Res Commun; 2005 Jul; 332(4):923-6. PubMed ID: 15949465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation in the genesis of hypertension and its complications--the role of angiotensin II.
    Li J; Doerffel Y; Hocher B; Unger T
    Nephrol Dial Transplant; 2007 Nov; 22(11):3107-9. PubMed ID: 17698879
    [No Abstract]   [Full Text] [Related]  

  • 14. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
    Beckman JA; Preis O; Ridker PM; Gerhard-Herman M
    Am J Cardiol; 2005 Nov; 96(10):1374-8. PubMed ID: 16275181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease.
    Taylor AJ; Bobik A; Richards M; Kaye D; Raines G; Gould P; Jennings G
    Am Heart J; 2004 Aug; 148(2):e10. PubMed ID: 15309013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial reperfusion injury and the challenging quest for its prevention.
    Merx MW; Kelm M
    Crit Care Med; 2007 Jul; 35(7):1793-4. PubMed ID: 17581372
    [No Abstract]   [Full Text] [Related]  

  • 18. TNF-alpha/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North Indian patients with acute myocardial infarction.
    Goswami B; Rajappa M; Mallika V; Shukla DK; Kumar S
    Clin Chim Acta; 2009 Oct; 408(1-2):14-8. PubMed ID: 19576194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan improves cardiopulmonary resuscitation and survival by K(ATP) channel activation.
    Cammarata GA; Weil MH; Sun S; Huang L; Fang X; Tang W
    J Am Coll Cardiol; 2006 Mar; 47(5):1083-5. PubMed ID: 16516098
    [No Abstract]   [Full Text] [Related]  

  • 20. We think we see a pattern emerging here.
    Downey JM; Cohen MV
    Circulation; 2005 Jan; 111(2):120-1. PubMed ID: 15657384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.